Intervention
Axillary Reverse Mapping
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 4 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownAxillary Node Dissection w or w/o LVB in Node Positive Breast Cancer PatientsNCT05970107 · 2026-06-01
NOT_YET_RECRUITINGImpact of the ARM Technique on the Prevention of Lymphedema After Axillary Lymphadenectomy: A Multicenter Randomized Clinical TrialNCT07515300 · 2026-03-01
ACTIVE_NOT_RECRUITINGAxillary Reverse Mapping for Invasive Carcinoma of the BreastNCT00645541 · 2008-03-01
COMPLETEDAxillary Reverse MappingNCT00572481 · 2007-05-01
ACTIVE_NOT_RECRUITINGCommon conditions
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING2
COMPLETED1
NOT_YET_RECRUITING1
Phase mix
NA2
PHASE11
PHASE21
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.